Ayala Pharmaceuticals Inc

NASDAQ:AYLA   3:59:50 PM EDT
1.69
-0.05 (-2.87%)
Earnings Announcements

Ayala Pharmaceuticals Reports Full-Year 2021 Financial Results

Published: 03/28/2022 20:26 GMT
Ayala Pharmaceuticals Inc (AYLA) - Ayala Pharmaceuticals Reports Full-year 2021 Financial Results and Provides Corporate Update.
Ayala Pharmaceuticals Inc - Cash and Cash Equivalents Were $37.3 Million As of December 31, 2021.
Revenue is expected to be $0.62 Million
Adjusted EPS is expected to be -$0.66

Next Quarter Revenue Guidance is expected to be $0.63 Million
Next Quarter EPS Guidance is expected to be -$0.59

More details on our Analysts Page.